FDA approves first treatment for breast cancer with a certain inherited genetic mutation
The FDA expanded the approved use of Lynparza (olaparib tablets) to include treatment of patients with certain types of breast cancer that have metastasized and whose tumors have a specific inherited genetic mutation, making it the first drug in its class approved to treat breast cancer. January 12, 2018